Skip to content

Neuropace, Inc. NPCE Allowance for credit losses

Allowance for credit losses at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$1.61M+15.0%
Biohaven logo
BiohavenBHVN
$0

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.

The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s allowance for credit losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s allowance for credit losses?
Neuropace, Inc. (NPCE) reported allowance for credit losses of $1.98M in Q4 2025.
How has Neuropace, Inc.'s allowance for credit losses changed year-over-year?
Neuropace, Inc.'s allowance for credit losses increased by 41.5% year-over-year, from $1.4M to $1.98M.
What is the long-term trend for Neuropace, Inc.'s allowance for credit losses?
Over 5 years (2020 to 2025), Neuropace, Inc.'s allowance for credit losses has grown at a 7.0% compound annual growth rate (CAGR), from $1.41M to $1.98M.
What does allowance for credit losses mean?
Reserve held against the loan portfolio for estimated future credit losses under the CECL methodology — a contra-asset reducing net loans.